Skye Bioscience appoints Dr. Praveen Tyle to board of directors

Skye Bioscience, Inc.

Appointed Dr. Praveen Tyle as independent director effective July 22, 2021.
Tyle will serve on compensation, audit, and nominating committees.
Receives $40,000 annual director fee plus $8,500 committee compensation.
Granted options for 250,000 shares; 10% vested immediately, remainder over 2 years.
Options fully vest upon change of control.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Praveen Tyle

Director

SKYE · Skye Bioscience, Inc.

Effective: 2021-07-22
Filed: July 26, 2021, 7:59 PM ET

Effective July 22, 2021, the Board of Directors (the “Board”) of Skye Bioscience, Inc., a Nevada corporation (the “Company”) increased the size of the Board from three to four directors and elected Dr. Praveen Tyle, Ph.D. to fill such vacancy and serve as a director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Praveen Tyle was elected as Director at Skye Bioscience, Inc..

Action: elected
Role: Director

Exact text from the filing

Effective July 22, 2021, the Board of Directors (the “Board”) of Skye Bioscience, Inc., a Nevada corporation (the “Company”) increased the size of the Board from three to four directors and elected Dr. Praveen Tyle, Ph.D. to fill such vacancy and serve as a director

View on SEC.gov

Skye Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001640334-21-001671

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.